BIOLARGO, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3525 USD | +2.78% |
|
+3.80% | +109.82% |
| Apr. 02 | Transcript : BioLargo, Inc., Q4 2023 Earnings Call, Apr 02, 2024 | |
| Apr. 01 | BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Presentation Operator MessageOperator (Operator)Greetings. Welcome to the BioLargo Third Quart...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company invents, develops, and commercializes platform technologies to solve challenging environmental problems like polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater treatment, industrial odor control, air quality control, infection control, and myriad environmental remediation challenges. The Companyâs segments include ONM Environmental, which manufactures and sells its odor and VOC control products and services, including its flagship product, CupriDyne Clean; BLEST, which provides professional engineering services supporting its internal business units; Clyra Medical, which develops and sells medical products based on its technology; BioLargo Canada, which is primary engaged in research and development activities; and Corporate Operations, which support the operating segments with legal, accounting, human resources, and other services.
Sector
Commodity Chemicals
Calendar
2024-05-14
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3525
USD
Average target price
0.35
USD
Spread / Average Target
-0.71%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +109.82% | 104M | |
| +5.14% | 103B | |
| -5.63% | 63.04B | |
| +39.52% | 39.06B | |
| +12.91% | 37.58B | |
| +7.41% | 33.26B | |
| +6.85% | 19.22B | |
| +12.86% | 16.83B | |
| +7.73% | 15.03B | |
| +16.93% | 14.96B |
- Stock Market
- Equities
- BLGO Stock
- News BioLargo, Inc.
- Transcript : BioLargo, Inc., Q3 2023 Earnings Call, Nov 20, 2023
